Foresight Capital Management Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-995
Closed -$281K 94
2025
Q3
$281K Hold
995
0.16% 66
2025
Q2
$278K Buy
995
+13
+1% +$3.68K 0.16% 66
2025
Q1
$306K Hold
982
0.19% 63
2024
Q4
$256K Hold
982
0.15% 64
2024
Q3
$316K Buy
982
+50
+5% +$16.4K 0.19% 56
2024
Q2
$291K Hold
932
0.2% 51
2024
Q1
$265K Hold
932
0.2% 54
2023
Q4
$268K Buy
+932
New +$254K 0.27% 40

Other funds holding AMGN

Foresight Capital Management Advisors's AMGN Position: Q4 2025 in Review

Foresight Capital Management Advisors sold out of Amgen (AMGN) in Q4 2025, closing a stake of 995 shares — an estimated $281K sold.

Foresight Capital Management Advisors first reported a position in AMGN in Q4 2023 and held it in 8 quarters. The position peaked at $316K in Q3 2024. 3,086 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Foresight Capital Management Advisors reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Foresight Capital Management Advisors sold 995 Amgen shares in Q4 2025, an estimated $281K.
  • Foresight Capital Management Advisors first reported a position in Amgen in Q4 2023 and held it in 8 quarters.
  • Foresight Capital Management Advisors's Amgen position peaked at $316K in Q3 2024.
  • 3,086 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Foresight Capital Management Advisors's 13F filing for Q4 2025, filed 28 Jan 2026.